Glycemic control in non-critically ill hospitalized patients: a systematic review and meta-analysis.
暂无分享,去创建一个
Mohammad Hassan Murad | Victor M Montori | V. Montori | M. Murad | M. Lane | L. Prokop | F. Coto-Yglesias | Fernando Coto-Yglesias | J. Coburn | John A Coburn | Svitlana Dzyubak | Ahmad Hazem | Melanie A Lane | Larry J Prokop | A. Hazem | Svitlana Dzyubak | Melanie A. Lane | Fernando Coto‐Yglesias
[1] G. Van den Berghe,et al. Intensive insulin therapy in the medical ICU. , 2006, The New England journal of medicine.
[2] Limin Peng,et al. Randomized Study of Basal-Bolus Insulin Therapy in the Inpatient Management of Patients With Type 2 Diabetes Undergoing General Surgery (RABBIT 2 Surgery) , 2011, Diabetes Care.
[3] Stephane Heritier,et al. Intensive versus conventional glucose control in critically ill patients. , 2009, The New England journal of medicine.
[4] W. Hueston,et al. Glycemic Control in Medical Inpatients with Type 2 Diabetes Mellitus Receiving Sliding Scale Insulin Regimens versus Routine Diabetes Medications: A Multicenter Randomized Controlled Trial , 2003, The Annals of Family Medicine.
[5] L. Mandarino,et al. Cortisol-induced insulin resistance in man: impaired suppression of glucose production and stimulation of glucose utilization due to a postreceptor detect of insulin action. , 1982, The Journal of clinical endocrinology and metabolism.
[6] R. Mcnutt,et al. Eliminating inpatient sliding-scale insulin: a reeducation project with medical house staff. , 2005, Diabetes care.
[7] R. Clements,et al. Rapid insulin initiation in non-insulin-dependent diabetes mellitus. , 1987, The American journal of medicine.
[8] M. Mclean,et al. The Hyperglycemia: Intensive Insulin Infusion in Infarction (HI-5) study: a randomized controlled trial of insulin infusion therapy for myocardial infarction. , 2006, Diabetes care.
[9] D. Kansagara,et al. Intensive Insulin Therapy in Hospitalized Patients: A Systematic Review , 2011, Annals of Internal Medicine.
[10] Xiangtong Zhang,et al. Intensive insulin therapy on infection rate, days in NICU, in-hospital mortality and neurological outcome in severe traumatic brain injury patients: a randomized controlled trial. , 2009, International journal of nursing studies.
[11] Gordon H Guyatt,et al. Patient-important outcomes in registered diabetes trials. , 2008, JAMA.
[12] Richard Hellman,et al. American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. , 2009, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.
[13] F. Brancati,et al. Perioperative glycemic control and the risk of infectious complications in a cohort of adults with diabetes. , 1999, Diabetes care.
[14] H. Krumholz,et al. Glucose normalization and outcomes in patients with acute myocardial infarction. , 2009, Archives of internal medicine.
[15] Diane Marshall,et al. Hyperglycemia predicts mortality after CABG: postoperative hyperglycemia predicts dramatic increases in mortality after coronary artery bypass graft surgery. , 2008, Journal of diabetes and its complications.
[16] L. Kennedy,et al. Randomized Study of Basal-Bolus Insulin Therapy in the Inpatient Management of Patients With Type 2 Diabetes (RABBIT 2 Trial) , 2008 .
[17] K.-A. Lee,et al. Sliding Scale Versus Tight Glycemic Control in the Noncritically III at a Community Hospital , 2009, The Annals of pharmacotherapy.
[18] D. Moher,et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement , 2009, BMJ : British Medical Journal.
[19] Felix Zijlstra,et al. Glucose-insulin-potassium infusion inpatients treated with primary angioplasty for acute myocardial infarction: the glucose-insulin-potassium study: a randomized trial. , 2003, Journal of the American College of Cardiology.
[20] E. Jéquier,et al. Effects of glucocorticoids and sympathomimetic agents on basal and insulin-stimulated glucose metabolism. , 1995, Clinical physiology.
[21] H Wedel,et al. Infarction : Long-Term Results From the Diabetes and Insulin-Glucose Infusion Conventionally Treated Patients With Diabetes Mellitus and Acute Myocardial Glycometabolic State at Admission : Important Risk Marker of Mortality in , 1999 .
[22] Douglas G Altman,et al. Interaction revisited: the difference between two estimates , 2003, BMJ : British Medical Journal.
[23] I. Olkin,et al. The case of the misleading funnel plot , 2006, BMJ : British Medical Journal.
[24] N. Laird,et al. Meta-analysis in clinical trials. , 1986, Controlled clinical trials.
[25] B. Glaser,et al. In-hospital treatment of hyperglycemia: effects of intensified subcutaneous insulin treatment , 2007, Current medical research and opinion.
[26] D. Altman,et al. Measuring inconsistency in meta-analyses , 2003, BMJ : British Medical Journal.
[27] M. Renvall,et al. Improved inpatient use of basal insulin, reduced hypoglycemia, and improved glycemic control: effect of structured subcutaneous insulin orders and an insulin management algorithm. , 2009, Journal of hospital medicine.
[28] G. Guyatt,et al. A case for clarity, consistency, and helpfulness: state-of-the-art clinical practice guidelines in endocrinology using the grading of recommendations, assessment, development, and evaluation system. , 2008, The Journal of clinical endocrinology and metabolism.
[29] G. Angelini,et al. Inadequate Blood Glucose Control Is Associated With In-Hospital Mortality and Morbidity in Diabetic and Nondiabetic Patients Undergoing Cardiac Surgery , 2008, Circulation.
[30] M Schetz,et al. Intensive insulin therapy in critically ill patients. , 2001, The New England journal of medicine.
[31] R. Eaton,et al. The temporal relationship between endogenously secreted stress hormones and metabolic decompensation in diabetic man. , 1980, The Journal of clinical endocrinology and metabolism.
[32] V. Pettilä,et al. Strict versus moderate glucose control after resuscitation from ventricular fibrillation , 2007, Intensive Care Medicine.
[33] Limin Peng,et al. Comparison of inpatient insulin regimens with detemir plus aspart versus neutral protamine hagedorn plus regular in medical patients with type 2 diabetes. , 2009, The Journal of clinical endocrinology and metabolism.
[34] J Herlitz,et al. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year. , 1995, Journal of the American College of Cardiology.
[35] I. Hirsch,et al. New insulin infusion protocol Improves blood glucose control in hospitalized patients without increasing hypoglycemia. , 2005, Joint Commission journal on quality and patient safety.
[36] G. Umpierrez,et al. Prevalence and Clinical Outcome of Hyperglycemia in the Perioperative Period in Noncardiac Surgery , 2010, Diabetes Care.
[37] Plamen Nikolov,et al. Economic Costs of Diabetes in the U.S. in 2002 , 2003, Diabetes care.
[38] M. Walters,et al. A Randomised, Controlled Pilot Study to Investigate the Potential Benefit of Intervention with Insulin in Hyperglycaemic Acute Ischaemic Stroke Patients , 2006, Cerebrovascular Diseases.
[39] J. Pomposelli,et al. Early postoperative glucose control predicts nosocomial infection rate in diabetic patients. , 1998, JPEN. Journal of parenteral and enteral nutrition.
[40] M. Laakso,et al. Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity , 2005 .